Cadrenal Therapeutics, Inc.
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.72 | -0.80 | -1.72 | -1.43 | -1.99 | -1.17 | -2.52 | -1.54 | -1.15 | -1.29 | -1.25 | -0.77 | -3.49 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.18 | 0.12 | 0.15 | 0.18 | 0.27 | 0.50 | 0.30 | 0.30 | 0.23 | 0.16 | 0.10 | 0.23 | 0.59 | |
| 0.29 | 0.40 | -0.31 | 0.63 | -0.08 | 1.07 | -0.74 | 0.02 | -0.07 | 0.07 | -0.32 | 0.07 | -0.19 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | – | |
| – | – | – | – | 0.00 | 0.00 | – | – | – | – | – | – | – | |
| 7.50 | -0.01 | 0.00 | 0.00 | 1.38 | 4.89 | 1.07 | 0.64 | 0.32 | 1.36 | 0.54 | 0.79 | 2.40 | |
| 6.77 | -0.81 | -1.72 | -1.43 | -0.61 | 3.71 | -1.45 | -0.90 | -0.84 | 0.07 | -0.71 | 0.03 | -1.09 | |
| -0.72 | -0.80 | -1.72 | -1.43 | -1.99 | -1.18 | -2.52 | -1.54 | -1.15 | -1.29 | -1.25 | -0.77 | -3.49 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.